Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
Abstract Radiation therapy is a source of tumor antigen release that has the potential to serve as an endogenous tumor vaccination event. In preclinical models radiation therapy synergizes with checkpoint inhibitors to cure tumors via CD8 T cell responses. To evaluate the immune response initiated b...
Guardado en:
Autores principales: | Marka R. Crittenden, Lauren Zebertavage, Gwen Kramer, Shelly Bambina, David Friedman, Victoria Troesch, Tiffany Blair, Jason R. Baird, Alejandro Alice, Michael J. Gough |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f487b6ccc674a53808df9b8692dc7ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production
por: Alejandro F. Alice, et al.
Publicado: (2021) -
Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy.
por: Marka R Crittenden, et al.
Publicado: (2012) -
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
por: Andrew Haydon, et al.
Publicado: (2021) -
Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
por: Pei-Yi Chu, et al.
Publicado: (2021) -
Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade
por: Kim M. Kraus, et al.
Publicado: (2021)